Successful reversal of the immunosuppressive microenvironment in bone metastatic tumors was realized by SB@HSCs‐PD‐1, thereby effectively reactivating anti‐tumor immunity in this immune‐privileged area. The gene discussed is PDCD1; the disease is neoplasm.